Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
The Annals of Pharmacotherapy|January 5, 2019
Neratinib in HER2-Positive Breast Cancer PatientsRutugandha Paranjpe, Dima Basatneh, Gabriel Tao, et al.
Breast Cancer Research and Treatment|April 16, 2025
Non-adherence of cyclin-dependent kinases 4 and 6 inhibitors reduces overall and progression-free survival in patients with hormone receptor-positive breast cancerConnie Lau, Krista LaBorde, Bilqees Fatima, et al.
Cancer Research|February 14, 2018
Perspective on Circulating Tumor Cell Clusters: Why It Takes a Village to MetastasizeMario Giuliano, Anum Shaikh, Hin Ching Lo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 25, 2019
Patient-reported outcomes in light of supportive medications in treatment-naïve lung cancer patientsJohnny M Hoang, Navneet Upadhyay, Dozie N Dike, et al.
Iscience|June 30, 2025
The TWEAK/Fn14 signaling mediates skeletal muscle wasting during cancer cachexiaMeiricris Tomaz da Silva, Anirban Roy, Anh Tuan Vuong, et al.
Scientific Reports|February 5, 2022
NPY1R exerts inhibitory action on estradiol-stimulated growth and predicts endocrine sensitivity and better survival in ER-positive breast cancerRaksha Bhat, Hariprasad Thangavel, Noor Mazin Abdulkareem, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 11, 2025
Interventions to improve adherence to oral endocrine therapy for prevention or treatment of breast cancer in Black women of low socioeconomic statusCamille Johnson Powell, Ann Adigwe, Nicole Ekezie, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 10, 2021
A novel role of ADGRF1 (GPR110) in promoting cellular quiescence and chemoresistance in human epidermal growth factor receptor 2-positive breast cancerNoor Mazin Abdulkareem, Raksha Bhat, Lanfang Qin, et al.
Oncogene|April 6, 2026
TAK1 is a key regulator of oncogenic signaling and differentiation blockade in rhabdomyosarcomaAnh Tuan Vuong, Aniket S Joshi, Anirban Roy, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
TAK1 is a key regulator of oncogenic signaling and differentiation blockade in rhabdomyosarcomaAnh Tuan Vuong, Aniket S Joshi, Anirban Roy, et al.
Pageof 6